Literature DB >> 6270227

Induction of monocyte procoagulant activity by murine hepatitis virus type 3 parallels disease susceptibility in mice.

G A Levy, J L Leibowitz, T S Edgington.   

Abstract

The in vitro induction of procoagulant activity (PCA) in murine peripheral blood mononuclear cells (PBM) by murine hepatitis virus type 3 (MHV-3) correlates with the disease susceptibility in three strains of mice. PBM from BALB/c mice, a strain in which MHV-3 infection results in fatal acute fulminant hepatitis, responds to the virus with a robust PCA response, whereas PBM from C3H/St mice, a strain which develops mild acute hepatitis followed by chronic hepatitis, only exhibit a modest PCA response. In contrast, PBM from A/J mice, a strain fully resistant to MHV-3, generate no increase in PCA above control levels. The induction phase of MHV-3 PCA is rapid, with an increase within 1-1.5 h, with maximum activity at 18h, and it precedes MHV-3 replication in either 17 CL1 cells, a fully permissive cell line, or in monocytes from these strains of mice. The PCA response of BALB/c PBM exceeds the response to any other known stimulus. No induction occurs upon direct stimulation of monocytes by MHV-3, but in the presence of lymphocyte collaboration, the PCA response is observed first at a lymphocyte:monocyte ratio of 2:1 and reaches a maximum as the lymphocyte:monocyte ratio approaches 4:1. This response appears to provide a functional marker for susceptibility to MHV-3 infection in inbred strains of mice and could be important in the pathogenesis of MHV-3-induced disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6270227      PMCID: PMC2186492          DOI: 10.1084/jem.154.4.1150

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  35 in total

1.  Induction of cytocidal macrophages after in vitro interactions between Listeria-immune T cells and macrophages--role of H-2.

Authors:  A G Farr; W J Wechter; J M Kiely; E R Unanue
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

2.  Immunopathology of mouse hepatitis virus type 3 infection. III. Clinical and virologic observation of a persistent viral infection.

Authors:  C L Prévost; J L Virelizier; J M Dupuy
Journal:  J Immunol       Date:  1975-09       Impact factor: 5.422

3.  Fibrinopeptide A in plasma of normal subjects and patients with disseminated intravascular coagulation and systemic lupus erythematosus.

Authors:  M Cronlund; J Hardin; J Burton; L Lee; E Haber; K J Bloch
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

Review 4.  The immunopathology of joint inflammation in rheumatoid arthritis.

Authors:  N J Zvaifler
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

5.  Hepatitis and brain lesions due to mouse hepatitis virus accompanied by wasting in nude mice.

Authors:  A Sebesteny; A C Hill
Journal:  Lab Anim       Date:  1974-09       Impact factor: 2.471

6.  Esterases in human leukocytes.

Authors:  C Y Li; K W Lam; L T Yam
Journal:  J Histochem Cytochem       Date:  1973-01       Impact factor: 2.479

7.  Increased production and expression of tissue thromboplastin-like procoagulant activity in vitro by allogeneically stimulated human leukocytes.

Authors:  H Rothberger; T S Zimmerman; J H Vaughan
Journal:  J Clin Invest       Date:  1978-09       Impact factor: 14.808

8.  The role of human T cells (and T cell products) for monocyte tissue factor generation.

Authors:  R L Edwards; F R Rickles
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

Review 9.  The pathogenetic role of the coagulation process in glomerular diseases of immunologic origin.

Authors:  P Vassalli; R T McCluskey
Journal:  Adv Nephrol Necker Hosp       Date:  1971

10.  Blocking of in vitro and in vivo susceptibility to mouse hepatitis virus.

Authors:  W Y Weiser; F B Bang
Journal:  J Exp Med       Date:  1977-11-01       Impact factor: 14.307

View more
  64 in total

1.  Platelet-activating factor modulates endotoxin-induced macrophage procoagulant activity by a protein kinase C-dependent mechanism.

Authors:  D S Kucey; P Y Cheung; O D Rotstein
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

2.  Roles for thrombin and fibrin(ogen) in cytokine/chemokine production and macrophage adhesion in vivo.

Authors:  Frank M Szaba; Stephen T Smiley
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

3.  Murine hepatitis virus strain 1 produces a clinically relevant model of severe acute respiratory syndrome in A/J mice.

Authors:  Nadine De Albuquerque; Ehtesham Baig; Xuezhong Ma; Jianhua Zhang; William He; Andrea Rowe; Marlena Habal; Mingfeng Liu; Itay Shalev; Gregory P Downey; Reginald Gorczynski; Jagdish Butany; Julian Leibowitz; Susan R Weiss; Ian D McGilvray; M James Phillips; Eleanor N Fish; Gary A Levy
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

4.  Absence of monocyte procoagulant activity during the immune response to influenza virus.

Authors:  M Mathies; N Hogg
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

5.  16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection.

Authors:  M Abecassis; J A Falk; L Makowka; V J Dindzans; R E Falk; G A Levy
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

6.  Induction of macrophage procoagulant activity by murine hepatitis virus strain 3: role of tyrosine phosphorylation.

Authors:  A P Dackiw; K Zakrzewski; A B Nathens; P Y Cheung; R Fingerote; G A Levy; O D Rotstein
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

7.  The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis.

Authors:  Philip A Marsden; Qin Ning; Laisum S Fung; Xioping Luo; Yue Chen; Michael Mendicino; Anand Ghanekar; Jeremy A Scott; Teresa Miller; Camie W Y Chan; Mathew W C Chan; Wei He; Reginald M Gorczynski; David R Grant; David A Clark; M James Phillips; Gary A Levy
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

8.  Is lymphocyte co-operation necessary for thromboplastin synthesis by human monocytes?

Authors:  T Lyberg; H Prydz
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

9.  Virus specificity of the antiviral state induced by IFN gamma correlates with resistance to MHV 3 infection.

Authors:  I G Mello; R C Vassão; C A Pereira
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

10.  Inhibitory function of Tregs via soluble FGL2 in chronic hepatitis B.

Authors:  Li Xu; Daofeng Yang; Yanlin Liu; Di Wu; Xiaojing Wang; Qin Ning
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.